Fred, I'd say "D" in Australia is hanging her hat primarily on this particular link that you provided:
American Academy of Sleep Medicine Review which looked at a great many studies of autopaps.
I've lifted a few excerpts from the AASM review that sound very much like what she has seen or heard about.
The Use of Auto-Titrating Continuous Positive Airway Pressure for Treatment of Adult Obstructive Sleep Apnea
An American Academy of Sleep Medicine Review
SLEEP, Vol. 25, No. 2, 2002
(website Page 10)
p. 157 "Part 5.8 Are there safety considerations in selecting patients for auto-CPAP titration or treatment?"
"While most studies did not exclude patients needing high CPAP levels (>14 cm H2O), the average treatment pressure in most studies was in the 8 to 12 cm H2O range. No study specifically addressed APAP efficacy in the group requiring high CPAP pressures."
(website Page 11) p. 158 "Part 6.0 Future Research"
"Review of the current literature has identified several issues that need more information. There is little or no data comparing the effectiveness of different APAP technologies."
"There is conflicting data about whether chronic treatment with APAP can increase acceptance of or adherence to positive pressure treatment. To date, no study has shown APAP improves patient outcomes."
__________________________________________________
Of your links, this next one probably provides your best argument.
Your 4th link (actually third one, since link 2 & 3 were duplicates) went to this PDF article about a German study published in CHEST in 1998:
http://www.chestjournal.org/cgi/reprint/113/3/714
This study was cite #35 in the AASM review of studies.
"Use of Conventional and Self-Adjusting Nasal Continuous Positive Airway Pressure for Treatment of Severe Obstructive Sleep Apnea Syndrome*
A Comparative Study
Martin Konermann, MD; Bernd M. Sanner, MD; Martin Vyleta, MD; Frank Laschewski, MD; Juergen Groetz, MD; Alexander Sturm, MD; and Walter Zidek, MD"
"Conclusion: Self-adjusting nCPAP demonstrates the same reliability in suppression of respiratory disturbances as fixed-mask pressure therapy. Sleep quality is slightly superior, patient compliance is highly significantly better. (CHEST 1998; 113:714-18)"
_____________________________________________
However, if "D" is, indeed, relying heavily on the AASM review, the three AASM reviewers had some quibbles with the German study.
The AASM's comments about the German study included this
(website Page 9) :
p. 156 "5.7 What is the evidence that auto-CPAP will increase acceptance or utilization with positive pressure treatment when used as long-term treatment for OSA?"
"Konermann et al. (35) also used a parallel design in which patients were randomized to fixed CPAP or APAP in-lab titration followed by a three-to-six-month treatment period using the same mode of positive pressure. Adherence was determined over that period. The number of nights per week with >4 hours use was greater in the APAP group (APAP: 6.5±0.4 vs. CPAP: 5.7±0.7 night per week). The mean nightly duration of use did not differ (5.6±2.5 with CPAP vs. 5.9±1.6 with APAP), and the fixed CPAP and APAP groups were well matched. However, the exact details of the timing of when adherence monitoring occurred were not provided. Thus, one cannot determine if adherence was sampled at equivalent times in the two groups. The APAP group had more slow wave sleep on the initial treatment night. This group may have responded better on average to positive pressure and thus potentially might be more adherent. Furthermore, it was not documented that the small difference in adherence resulted in any difference in outcomes."
______________________________________________
I wonder if the three people preparing the AASM report were not just a tiny bit biased against autopap? I don't quite see why they came up with this comment about the German study (emphasis mine):
"The APAP group had more slow wave sleep on the initial treatment night.
This group may have responded better on average to positive pressure and thus potentially might be more adherent."
Seems to me an equally plausible comment could have been stated like this (my words, not the AASM reviewers' words!): "An increase in slow wave sleep on the initial treatment night of the APAP group may have demonstrated better treatment and thus might have made that group more adherent."
At any rate, Fred, thought you might want to be forewarned about whether the AASM review was the right kind of ammunition or not for a chat with "D".
I'm a believer in autopap, but if a person is going to butt heads over "studies" with a sleep professional who may be relying on the American Academy of Sleep Medicine's review of other studies, I'm afraid that link won't get you very far.
P.S. About this link:
http://ajrccm.atsjournals.org/cgi/conte ... 163/6/1295
Patric Lévy and Jean-Louis Pépin (the authors) are consultants to Mallinckrodt.
Mallinckrodt is associated with Puritan Bennett - manufacturers of the Goodknight cpap, autopap, and bi-level machines. There would be a vendor sponsored connection in that study.